drugset / Trial / NCT01180179

PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers

NCT01180179

Phase 4 Completed 228 enrolled Chinese University of Hong Kong
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is to compare the efficacy of a proton pump inhibitor (lansoprazole) and a histamine-2 receptor antagonist (famotidine) in preventing recurrent ulcer bleeding in patients with a history of H. pylori-negative idiopathic peptic ulcers.

Timeline

Start
2010-06
Primary completion
2019-05
Completion
2019-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Famotidine Other / unclassified 40 mg Oral
Comparator Lansoprazole Other / unclassified 30 mg Oral

Indications